Cancer Biomarkers Market
According to Intent Market Research, the Cancer Biomarkers Market is expected to grow from USD 19.7 billion in 2023 at a CAGR of 6.8% to touch USD 31.2 billion by 2030. The Cancer Biomarkers Market is dominated by key players such as, Agilent Technologies, Inc., Abbott Laboratories, Genomic Health, Inc., QIAGEN N.V., and Hologic, Inc.